P & G Health Ltd

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
4,874.55
52.95 (1.1%)
BSENSE

Mar 20

BSE+NSE Vol: 30.25 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Dec'24
Sep'24
Dec'23
Dec'22
Dec'21
Dec'20
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 11.11%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 56.11%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 29.77%

stock-summary

Interest

Growth in half year ended Sep 2025 is -31.43%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of P & G Health Ltd With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
663.66
1,020.77
-357.11
-34.98%
Other Operating Income
0.00
0.00
0.00
Total Operating income
663.66
1,020.77
-357.11
-34.98%
Raw Material Cost
137.67
466.64
-328.97
-70.50%
Purchase of Finished goods
34.95
45.76
-10.81
-23.62%
(Increase) / Decrease In Stocks
-10.23
11.82
-22.05
-186.55%
Employee Cost
109.89
190.53
-80.64
-42.32%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
-0.01
0.01
100.00%
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
180.77
176.58
4.19
2.37%
Total Expenditure (Excl Depreciation)
453.05
891.32
-438.27
-49.17%
Operating Profit (PBDIT) excl Other Income
210.61
129.45
81.16
62.70%
Other Income
8.98
15.85
-6.87
-43.34%
Operating Profit (PBDIT)
219.59
145.30
74.29
51.13%
Interest
0.24
59.86
-59.62
-99.60%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
219.35
85.44
133.91
156.73%
Depreciation
11.52
43.65
-32.13
-73.61%
Profit Before Tax
207.83
41.79
166.04
397.32%
Tax
53.11
-3.60
56.71
1,575.28%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
154.72
45.39
109.33
240.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
154.72
45.39
109.33
240.87%
Equity Capital
16.60
92.17
-75.57
-81.99%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
93.20
4.92
88.28
1,794.31%
Diluted Earnings per share
93.21
4.92
88.29
1,794.51%
Operating Profit Margin (Excl OI)
31.73%
12.68%
0.00
19.05%
Gross Profit Margin
33.05%
8.37%
0.00
24.68%
PAT Margin
23.31%
4.45%
0.00
18.86%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 663.66 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 11.11%

Half Yearly - Standalone Net Profit
Standalone Net Profit 154.72 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 56.11%

Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 210.61 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is 29.77%

Half Yearly - Interest
Interest 0.24 Cr
in Sep 2025

Figures in Cr
stock-summary

Growth in half year ended Sep 2025 is -31.43%

Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.73%
in Sep 2025

Figures in %
stock-summary

Growth in half year ended Sep 2025 has improved from Sep 2024